- conflicts or gaps
- [{"operating_status_conflict": {"value": "YC, Craft.co, CB Insights, and Reforgers list Active/Alive; BioPharmGuy lists defunct citing CA filings Jun 2024–Oct 2025; co-founder CTO departed May 2024; website returned 503.", "source_urls": ["https://www.ycombinator.com/companies/synkrino-biotherapeutics", "https://craft.co/synkrino-biotherapeutics", "https://www.cbinsights.com/company/sf17-therapeutics", "https://biopharmguy.com/company.php/Synkrino%20Biotherapeutics", "https://www.linkedin.com/in/david-ott-2794b038", "https://www.synkrino.bio/"]}, "funding_total_conflict": {"value": "CB Insights reports $120K over 3 rounds; Tracxn reports $150K in 1 Seed round; GetLatka reports $0 (bootstrapped). 2021 round amount undisclosed.", "source_urls": ["https://www.cbinsights.com/company/sf17-therapeutics/financials", "https://tracxn.com/d/companies/synkrino/__aYzT5QPzCDz0rFhvOS8KT7Lq9PjAvtloxa6WORKM4TU", "https://getlatka.com/companies/synkrino.bio"]}, "hq_location_conflict": {"value": "Oakland (YC, Craft, Reforgers) vs San Francisco (CB Insights) vs Berkeley (Tracxn).", "source_urls": ["https://www.ycombinator.com/companies/synkrino-biotherapeutics", "https://craft.co/synkrino-biotherapeutics", "https://www.cbinsights.com/company/sf17-therapeutics", "https://tracxn.com/d/companies/synkrino/__aYzT5QPzCDz0rFhvOS8KT7Lq9PjAvtloxa6WORKM4TU"]}, "founder_attribution_conflict": {"value": "YC and Startup Intros list Barbour (CEO) and Ott (CTO); Tracxn lists only David Ott as founder; GetLatka lists only Jason Barbour as founder.", "source_urls": ["https://www.ycombinator.com/companies/synkrino-biotherapeutics", "https://startupintros.com/orgs/synkrino-biotherapeutics", "https://tracxn.com/d/companies/synkrino/__aYzT5QPzCDz0rFhvOS8KT7Lq9PjAvtloxa6WORKM4TU", "https://getlatka.com/companies/synkrino.bio"]}, "exit_details_gap": {"value": "No acquisition or IPO confirmed. BioPharmGuy defunct claim not independently verified against primary CA SOS records in this research.", "source_urls": ["https://tracxn.com/d/companies/synkrino/__aYzT5QPzCDz0rFhvOS8KT7Lq9PjAvtloxa6WORKM4TU", "https://biopharmguy.com/company.php/Synkrino%20Biotherapeutics"]}, "revenue_gap": {"value": "No verified public revenue figures.", "source_urls": ["https://getlatka.com/companies/synkrino.bio", "https://www.cbinsights.com/company/sf17-therapeutics/financials"]}, "product_line_staleness": {"value": "CB Insights COVID-19 field-test and pediatric-rheumatology monitoring descriptions may reflect older positioning vs SATIS-centric narrative on YC/Startup Intros.", "source_urls": ["https://www.cbinsights.com/company/sf17-therapeutics", "https://www.ycombinator.com/companies/synkrino-biotherapeutics", "https://startupintros.com/orgs/synkrino-biotherapeutics"]}}]
- source urls
- ["http://www.w9ein.com/FEIN/company_overview.php/EIN/830678961/CompanyName/SF17+THERAPEUTICS%2C+INC.", "https://biopharmguy.com/company.php/Synkrino%20Biotherapeutics", "https://craft.co/synkrino-biotherapeutics", "https://getlatka.com/companies/synkrino.bio", "https://reforgers.com/startups/synkrino-biotherapeutics", "https://startupintros.com/orgs/synkrino-biotherapeutics", "https://synkrino.dev/", "https://tracxn.com/d/companies/synkrino/__aYzT5QPzCDz0rFhvOS8KT7Lq9PjAvtloxa6WORKM4TU", "https://www.cbinsights.com/company/sf17-therapeutics", "https://www.cbinsights.com/company/sf17-therapeutics/financials", "https://www.linkedin.com/in/david-ott-2794b038", "https://www.linkedin.com/in/jbarbourphd", "https://www.linkedin.com/posts/davidott4_satis-ai-synkrino-activity-7123475318975152128-XRh0", "https://www.synkrino.bio/", "https://www.ycombinator.com/companies/synkrino-biotherapeutics"]